| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |